Vaxdyn wins one of the gold awards of the AcexHealth, Health Accelerator of Andalucía

GRANADA, SPAIN – Ten companies headquartered in Andalucía, five from the drugs & diagnostics sector and five from the digital health sector participated in the Investor Day, the closing ceremony of the AcexHealth accelerator program managed brilliantly from the Health Sciences Tech Park of Granada, Spain, and sponsored by relevant public and private entities based on Andalucía. Vaxdyn presented its unique technology of development of vaccines to prevent infections by the most clinically relevant antibiotic-resistant bacteria, with its lead candidate against Klebsiella pneumoniae ready to begin the path to the first in human trial, a decisive milestone. The jury valued Vaxdyn’s proposal to tackle the silent pandemic of antibiotic-resistance and gave Vaxdyn one of the two gold prizes of the event, including a cash award and a travel award for participation in a road show in Boston next May. The other gold-award went to PlusVitech and its proposal to fight cancer. The silver and bronze awards honored digital health projects from Adhera Health and Heuristik Health. The former’s main value proposition based on improving life of people with chronic conditions and the latter’s based on improving patient identification in healthcare.

The final messages from Vaxdyn’s CEO Juanjo Infante were: “This award means that the value of Vaxdyn’s proposal to fight antibiotic-resistance is well recognized, I would say that it is recognized with enthusiasm by experienced business and academic stakeholders in the health sector. We see our efforts compensated when others tell us about the value we are creating for society. I was also very proud to see the maturity of all the projects presented, meaning the consolidation of a true biotech sector in Andalucía with products and services already in the market”.

Vaxdyn thanks the Acexhealth program and its mentors for all the learning acquired in the last months participating in its different modules. And thanks all the sponsors that made possible this special event. Bidafarma, the sponsor behind our gold award, and Adamed, Vithas, Vircell, Coviran, PTS Granada Foundation, the University of Granada, the business chamber of Granada, and the Junta de Andalucía. Let’s keep creating value together.

About Vaxdyn S.L.

Vaxdyn is dedicated to improving quality of life in populations affected by infections globally. Vaxdyn’s vision is to create specific immunity in high-risk populations against the most antibiotic resistant bacterial pathogens. Headquartered in Seville, Spain, Vaxdyn works with an international network of collaborators in the development of multi-pathogen vaccines for preventing infections in individuals affected by chronic diseases of the lungs, liver, kidney, immunocompromised by several co-morbidities such as diabetes or cancer, and populations associated with nursing homes and hospital settings. Vaxdyn is strongly committed to constribute to reducing antibiotic use in the world by following a One-Health approach.

CEO Contact

Juan José Infante

[email protected]

Media Contact

María Teresa Díaz

[email protected]